Risk, Innovation and Early Access On The Menu At "EU50" Anniversary Event
This article was originally published in Scrip
This year marks the 50th anniversary of the first European law on the marketing authorization of medicines, Directive 65/65/EEC, which came into effect on 26 January 1965.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.